Mishchenko, O. Y. ., Adonkina, V. Y. ., & Greshko, I. I. (2025). The substantiation of the cost optimization for ER(+) HER2(−) breast cancer hormone therapy based on the results of the cost minimization pharmacoeconomic analysis. Social Pharmacy in Health Care, 11(1), 72–79. https://doi.org/10.24959/sphhcj.25.349